"Drug trials under pressure" is a strange title from USA Today for an article suggesting pharma is struggling to prove their drugs work.
Drug cos. solution recently, and perhaps since the beginning, is selectively choosing which data to use from their studies conducted in collaboration with universities nationwide. Naturally, drug cos. encourage the use of data which shows benefit from the use of their drugs while concealing/ignoring data showing no effectiveness.
The evidence in the form of a smoking gun for this ethically questionable practice is not out yet. But I foresee Congressional investigations in the next two years and hopefully serious reform in the next five years.
I'm not against drug manufacturing. Indeed, we need better drugs. However, I want to see them developed safely and the data presented openly and with transparency.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment